Pulmonary function abnormalities in patients with ulcerative colitis

American Journal of Gastroenterology

Volumn 92, Issue 7, 1997, Pages 1154-1156

  Godet, P G ^a   Cowie, R ^a   Woodman, R C ^a   Sutherland, L R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BEHAVIOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SMOKING; SURVIVAL RATE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 0030871418     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Retsky JE, Kraft SC. The extraintestinal manifestations of inflammatory bowel disease in inflammatory bowel diseases. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease, 4th Ed. Baltimore: Williams & Wilkins, 1995:474-91.
2. Monsen U, Sorstad J, Hellers G, et al. Extracolonic diagnoses in ulcerative colitis: An epidemiological study. Am J Gastroenterol 1990; 85:711-6.
3. Isenberg JI, Goldstein H, Korn AR, et al. Pulmonary vasculitis, an uncommon complication of ulcerative colitis. N Engl J Med 1968;279: 1376-7.
4. Moles KW, Varghese G, Hayes JR. Pulmonary involvement in ulcerative colitis. Br J Dis Chest 1988;82:79-83.
5. Gionchetti P, Schiavina M, Campieri M, et al. Bronchopulmonary involvement in ulcerative colitis. J Clin Gastroenterol 1990; 12:647-50.
6. Kraft SC, Earle RH, Roesler M, et al. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136: 454-9.
7. Patwardhan RV, Heilpern J, Brewster AC, et al. Pleuropericarditis: An extraintestinal manifestation of inflammatory bowel disease. Arch Intern Med 1983;143:94-6.
8. McKee AL, Rajapaksa A, Kalish PE, et al. Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis. Am J Gastroenterol 1983;78:86-9.
9. Gabazza EC, Taguchi O, Yamakami T, et al. Bronchopulmonary disease in ulcerative colitis. Intern Med 1992;31:1155-9.
10. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest 1989;95:1342-4.
11. Balestra DJ, Balestra ST, Wasson JH. Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease: A trial of N = 1. JAMA 1988;260:62-4.
12. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine 1993;72:151-83.
13. Yaffe BH, Korelitz BI. Sulfasalazine pneumonitis. Am J Gastroenterol 1983;78:493-4.
14. Jones GR, Malone DNS. Sulphasalazine induced lung disease. Thorax 1972;27:713-7.
15. Davies D, MacFarlane A. Fibrosing alveolitis and treatment with sulphasalazine. Gut 1974;15:185-8.
16. Reinoso MA, Schroeder KW, Pisani RJ. Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 1992;101: 1469-71.
17. Gabazza EC, Tagushi O, Yamakami T, et al. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine. Am J Gastroenterol 1992;87:1654-7.
18. Swinburn CR, Jackson GJ, Cobden I, et al. Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis. Thorax 1988;43:735-6.
19. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: A population based study. Gastroenterology 1992;103:954-60.
20. Heatley RV, Thomas P, Propkipchuk JG, et al. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med 1982;203:241-50.
21. Eade OE, Smith CL, Alexander JR, et al. Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol 1980; 73:154-6.
22. Johnson NM, Mee AS, Jewell DP, et al. Pulmonary function in inflammatory bowel disease. Digestion 1978;18:416-8.
23. Crapo DO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet American Thoracic Society recommendations. Am Rev Respir Dis 1981;123:659-64.
24. Crapo RD, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123: 185-9.
25. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
26. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 1989;6:12-3.
27. Boker KHW, Gehrdes R, Welte T, et al. Pulmonary complications in inflammatory bowel disease. Gastroenterology 1994;106:A655.
28. Rokaw SN, Detels R, Coulson AH, et al. The UCLA population studies of chronic obstructive respiratory disease. Chest 1980;78:252-60.
29. Department of Health and Human Services. The health consequences of smoking: Chronic obstructive lung disease. A report of the Surgeon General. DHHS (PHS) 1984;85-50207.